Analysis of a coded panel of licensed vaccines by polymerase chain reaction-based reverse transcriptase assays: A collaborative study

被引:11
作者
Maudru, T [1 ]
Peden, KWC [1 ]
机构
[1] US FDA, Lab Retrovirus Res, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
coded panel; licensed vaccines; polymerase chain reaction-based reverse transcriptase assays; reverse transcriptase;
D O I
10.1016/S0928-0197(98)00044-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: A recent publication reporting the presence of low levels of reverse transcriptase (RT) activity in certain vaccines for human use necessitated that regulatory agencies address the issue of whether this RT activity presented a risk to humans. Detection of low levels of RT activity corresponding to fewer than ten virions became possible with the development of highly-sensitive polymerase chain reaction (PCR)-based RT (PBRT) assays. Variations of the PERT assay were developed in three laboratories. These assays were reported as being at least one million-fold more sensitive than conventional RT assays. Objective: To ascertain the sensitivity and reliability of PERT assays in different laboratories and to determine which vaccine samples possessed RT activity. Study design: Coded panels of licensed vaccines together with positive and negative controls was assembled at the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) and distributed to five cooperating laboratories as well as to our laboratory at CBER. Each laboratory carried out their version of the PERT assay and submitted the results to the coordinator at CBER. Results: Results of the PERT analyses carried out in the six laboratories are presented. Five of the six laboratories reported results that were highly consistent. RT activity was detected in live attenuated vaccines that were prepared in chick embryo cells (mumps, measles and yellow fever), but very low or undetectable RT activity was found in vaccines produced in mammalian cells (rabies and rubella). Influenza vaccines from several manufacturers included in the panel displayed the most variability, with different products of this inactivated vaccine having differing amounts of RT activity. Conclusions: Only vaccines produced in chick embryo cells had significant RT activity. Because RT activity was present in the allantoic fluid of uninfected chick embryos and culture medium from chick embryo fibroblasts, the RT activity arises from the cell substrate used for vaccine production. The PERT assays were reliably able to detect the low levels of RT activity in chicken-derived vaccines. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 21 条
[1]   PURIFICATION AND FURTHER CHARACTERIZATION OF AN RNA-DEPENDENT DNA-POLYMERASE FROM ALLANTOIC FLUID OF LEUKOSIS-VIRUS-FREE CHICKEN EGGS [J].
BAUER, G ;
JILEK, G ;
HOFSCHNEIDER, PH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1977, 79 (02) :345-354
[2]   PURIFICATION AND CHARACTERIZATION OF PARTICLES CONTAINING RNA-DEPENDENT DNA-POLYMERASE, IN ALLANTOIC FLUID OF UNINFECTED LEUKOSIS VIRUS-FREE CHICKEN EGGS [J].
BAUER, G ;
FRIIS, RR ;
JILEK, G ;
HOFSCHNEIDER, PH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 518 (01) :125-137
[3]   RNA-DEPENDENT DNA-POLYMERASE, DIFFERENT FROM KNOWN VIRAL REVERSE TRANSCRIPTASES, IN CHICKEN SYSTEM [J].
BAUER, G ;
HOFSCHNEIDER, PH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (09) :3025-3029
[4]   RADIOIMMUNOLOGICAL COMPARISON OF THE DNA-POLYMERASES OF AVIAN RETROVIRUSES [J].
BAUER, G ;
TEMIN, HM .
JOURNAL OF VIROLOGY, 1980, 33 (03) :1046-1057
[5]   Detection of reverse transcriptase activity in live attenuated virus vaccines [J].
Boni, J ;
Stalder, J ;
Reigel, F ;
Schupbach, J .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1996, 5 (01) :43-53
[6]   Development of an improved product enhanced reverse transcriptase assay [J].
Chang, A ;
Ostrove, JM ;
Bird, RE .
JOURNAL OF VIROLOGICAL METHODS, 1997, 65 (01) :45-54
[7]   DETECTION OF REVERSE-TRANSCRIPTASE BY A HIGHLY SENSITIVE ASSAY IN SERA FROM PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
HENEINE, W ;
YAMAMOTO, S ;
SWITZER, WM ;
SPIRA, TJ ;
FOLKS, TM .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1210-1216
[8]   PURIFICATION OF DNA POLYMERASE OF AVIAN MYELOBLASTOSIS VIRUS [J].
KACIAN, DL ;
WATSON, KF ;
BURNY, A ;
SPIEGELM.S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1971, 246 (03) :365-+
[9]   DETECTION OF REPLICATION-COMPETENT AND PSEUDOTYPED HUMAN-IMMUNODEFICIENCY-VIRUS WITH A SENSITIVE CELL-LINE ON THE BASIS OF ACTIVATION OF AN INTEGRATED BETA-GALACTOSIDASE GENE [J].
KIMPTON, J ;
EMERMAN, M .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2232-2239
[10]   RADIOIMMUNOASSAY FOR MAMMALIAN TYPE-C VIRAL REVERSE-TRANSCRIPTASE [J].
KRAKOWER, JM ;
BARBACID, M ;
AARONSON, SA .
JOURNAL OF VIROLOGY, 1977, 22 (02) :331-339